Clinical Trials Logo

Hantaan Virus clinical trials

View clinical trials related to Hantaan Virus.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02776761 Completed - Hantaan Virus Clinical Trials

A Single-blind Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Hantaan Puumala Virus DNA Vaccine

Start date: August 30, 2016
Phase: Phase 1
Study type: Interventional

This is a single-center, randomized, single-blinded study of the Hantaan virus HTNV DNA vaccine alone, Puumala virus PUUV DNA vaccine alone, and mixed Hantaan/Puumala HTNV/PUUV DNA vaccines delivered intramuscularly IM by the needle-free PharmaJet Stratus DSJI device.